1. Home
  2. AGMB vs MG Comparison

AGMB vs MG Comparison

Compare AGMB & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$5.54

Market Cap

576.2M

Sector

Health Care

ML Signal

N/A

Logo Mistras Group Inc

MG

Mistras Group Inc

N/A

Current Price

$20.20

Market Cap

642.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
AGMB
MG
Founded
2017
1978
Country
Belgium
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
576.2M
642.4M
IPO Year
2024
2008

Fundamental Metrics

Financial Performance
Metric
AGMB
MG
Price
$5.54
$20.20
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $37.67
$21.18
AVG Volume (30 Days)
297.3K
★ 356.5K
Earning Date
12-01-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.51
Revenue
N/A
★ $700,970,000.00
Revenue This Year
N/A
$3.15
Revenue Next Year
N/A
$4.39
P/E Ratio
★ N/A
$39.58
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$11.15
52 Week High
$17.82
$21.92

Technical Indicators

Market Signals
Indicator
AGMB
MG
Relative Strength Index (RSI) 23.66 43.99
Support Level N/A $20.06
Resistance Level $9.55 $21.77
Average True Range (ATR) 0.69 0.06
MACD -0.04 -0.01
Stochastic Oscillator 5.17 43.33

Price Performance

Historical Comparison
AGMB
MG

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.

Share on Social Networks: